Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
A research team at South Korea-based Pohang University of Science and Technology (POSTECH), in collaboration with Dr San...
Medical Korea 2022 will be held on March 10 and 11 at the Korea International Exhibition and Convention Center (Coe...
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...
South Korea-based startup Aston Sci. has announced the completion of the Series C funding at a scale of $22.7 milli...
Genome and Company, a leading global microbiome anti-cancer drug development company in Korea, has entered into a first ...
GC Labs, the leading clinical diagnostics company in Korea, has announced the new lab testing service a...
Seegene Inc., South Korea's leading molecular diagnostics company, has announced the appointment of Dr. Richard S. ...
A research team led by Nano-Bio Convergence at the Korea Institute of Materials Science (KIMS) succeeded in develop...
GI Innovation, based in South Korea, has signed a biomarker joint research MoU with CellKey, a Glycoprotein biomarker de...
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...
A research team at Pohang University of Science and Technology in South Korea, in collaboration with the Department...
The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare (MOHW), Republic of ...
Solve.Care has announced the appointment of Dr Uhn Lee as the company’s president in Korea. Dr Lee has more than 3...
Seegene Inc, South Korea's molecular diagnostic startup, has announced that it has signed a supply deal with t...
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for inflam...
Celltrion Group, based in South Korea, has submitted an Investigational New Drug (IND) application to conduct a global P...
EuBiologics, a South Korean biotech company, has announced that EuCorVac-19, a COVID-19 vaccine candidate obtained appro...
